Skip to main content

Peer Review reports

From: Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients

Original Submission
25 Jul 2010 Submitted Original manuscript
31 Jul 2010 Author responded Author comments - Gabriella Ferrandina
Resubmission - Version 2
31 Jul 2010 Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
18 Oct 2010 Reviewed Reviewer Report - Maurie Markman
14 Dec 2010 Reviewed Reviewer Report - Sandro Pignata
26 Dec 2010 Reviewed Reviewer Report - Filippo Bellati
29 Dec 2010 Reviewed Reviewer Report - David Tan
30 Dec 2010 Reviewed Reviewer Report - Stephen Ackland
17 Feb 2011 Author responded Author comments - Gabriella Ferrandina
Resubmission - Version 4
17 Feb 2011 Submitted Manuscript version 4
6 Apr 2011 Reviewed Reviewer Report - Maurie Markman
11 Apr 2011 Reviewed Reviewer Report - Sandro Pignata
15 Apr 2011 Reviewed Reviewer Report - Stephen Ackland
26 Apr 2011 Reviewed Reviewer Report - Filippo Bellati
29 Apr 2011 Reviewed Reviewer Report - David Tan
15 May 2011 Author responded Author comments - Gabriella Ferrandina
Resubmission - Version 5
15 May 2011 Submitted Manuscript version 5
22 May 2011 Author responded Author comments - Gabriella Ferrandina
Resubmission - Version 6
22 May 2011 Submitted Manuscript version 6
Publishing
31 May 2011 Editorially accepted
31 May 2011 Article published 10.1186/1471-2407-11-214

You can find further information about peer review here.

Back to article page